Michael Gutknecht

504 total citations
17 papers, 309 citations indexed

About

Michael Gutknecht is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Michael Gutknecht has authored 17 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Michael Gutknecht's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Michael Gutknecht is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Michael Gutknecht collaborates with scholars based in United States, Germany and Japan. Michael Gutknecht's co-authors include Helmut R. Salih, Ryo Suzuki, Alexander L. Klibanov, Susanne M. Rittig, Frank Grünebach, Amy H. Bouton, Keena S. Thomas, Sara A. Mansfield, Martin Müller and Charles H. Cook and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Michael Gutknecht

16 papers receiving 309 citations

Peers

Michael Gutknecht
Alexandra Charruyer United States
Elke Wandel Germany
Kyu Yeon Han United States
Haelee Ahn United States
Ian Williamson United States
James E. Hayden United States
Alexandra Charruyer United States
Michael Gutknecht
Citations per year, relative to Michael Gutknecht Michael Gutknecht (= 1×) peers Alexandra Charruyer

Countries citing papers authored by Michael Gutknecht

Since Specialization
Citations

This map shows the geographic impact of Michael Gutknecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gutknecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gutknecht more than expected).

Fields of papers citing papers by Michael Gutknecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gutknecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gutknecht. The network helps show where Michael Gutknecht may publish in the future.

Co-authorship network of co-authors of Michael Gutknecht

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gutknecht. A scholar is included among the top collaborators of Michael Gutknecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gutknecht. Michael Gutknecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Karle, Anette, Karla Kopp, Robert Seward, et al.. (2025). MAPPs assays for non-clinical immunogenicity risk assessment: best practices recommended by the European immunogenicity platform. Frontiers in Immunology. 16. 1690101–1690101.
2.
Krenzlin, Harald, Deepak Ailani, Thomas Bukur, et al.. (2025). Cytomegalovirus-induced oncomodulation drives immune escape in glioblastoma. Scientific Reports. 15(1). 25981–25981. 1 indexed citations
3.
Marandu, Thomas F., Michael Gutknecht, Barbora Vlková, et al.. (2023). Cytomegalovirus durably primes neutrophil oxidative burst. Journal of Leukocyte Biology. 114(5). 459–474. 2 indexed citations
4.
Dörfel, Daniela, Christian Lechner, Simone Joas, et al.. (2018). The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells. Cancer Immunology Immunotherapy. 67(5). 775–783. 8 indexed citations
5.
Diakova, Galina, Ryo Suzuki, Anne M. Mills, et al.. (2018). Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer. Theranostics. 8(10). 2782–2798. 51 indexed citations
6.
Gutknecht, Michael, et al.. (2018). Focal adhesion kinase (FAK) deficiency in mononuclear phagocytes alters murine breast tumor progression.. PubMed. 8(4). 675–687. 10 indexed citations
7.
Märklin, Melanie, Jonas S. Heitmann, Michael Gutknecht, et al.. (2017). NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia. Nature Communications. 8(1). 755–755. 30 indexed citations
8.
Thomas, Keena S., et al.. (2017). The nonreceptor protein tyrosine kinase Pyk2 promotes the turnover of monocytes at steady state. Journal of Leukocyte Biology. 102(4). 1069–1080. 7 indexed citations
9.
Mansfield, Sara A., et al.. (2016). Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts. Journal of Medical Virology. 88(8). 1408–1416. 6 indexed citations
10.
Suzuki, Ryo, Michael Gutknecht, Lindsey T. Brinton, et al.. (2015). Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction. Journal of Controlled Release. 220(Pt A). 556–567. 54 indexed citations
11.
Gutknecht, Michael, Julian Geiger, Simone Joas, et al.. (2015). The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells. Cell Communication and Signaling. 13(1). 19–19. 44 indexed citations
12.
Mansfield, Sara A., et al.. (2015). Sepsis and cytomegalovirus: foes or conspirators?. Medical Microbiology and Immunology. 204(3). 431–437. 28 indexed citations
13.
Gutknecht, Michael, Simone Joas, Lothar Kanz, et al.. (2012). Monocyte-Derived Dendritic Cells Induce Functionally Active Regulatory T Cells Upon Exposure to BCR-ABL Tyrosine Kinase Inhibitors.. Blood. 120(21). 2156–2156. 1 indexed citations
14.
Thomas, Keena S., et al.. (2012). Regulation of osteoclast structure and function by FAK family kinases. Journal of Leukocyte Biology. 92(5). 1021–1028. 30 indexed citations
15.
Gutknecht, Michael, et al.. (2011). The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors. Cancer Immunology Immunotherapy. 61(2). 193–202. 32 indexed citations
17.
Breuninger, Helmut, Michael Gutknecht, Kelly R. Dietz, & G. Rassner. (1991). [Locally infiltrative growth of squamous cell carcinoma of the skin and treatment guidelines resulting from it].. PubMed. 42(9). 559–63. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026